MAGNA-PAGE
CancelledUS US · App #86938209 · Reg #5248598
Owned by
Bausch & Lomb IncorporatedApplication date
2016-03-13
Registration date
2017-07-25
Published date
2017-05-09
First use date
—
Renewal date
—
Expiry date
—
Kind of mark
Trademark
Mark feature
Word
NICE Classes
9Electronics & software
Domestic Classes
Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).
021023026036038
Current owners
Applicants
- Bausch & Lomb Incorporated
Previous owners
- Bausch & Lomb Incorporated
- Bausch & Lomb Incorporated
Correspondence
- [Nancy L. Rowe] Bausch + Lomb
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
21
Security: 8
Renewals
0
Prosecution events
60
Assignments & Security Interests
| Date | Conveyance | Assignor → Assignee | Type |
|---|---|---|---|
| 2025-11-07 | RELEASE OF SECURITY INTEREST IN TRADEMARKS AT REEL/FRAME 6280/0211 | THE BANK OF NEW YORK MELLON → ATON PHARMA, INC., CORIA LABORATORIES, LLC, ORAPHARMA, INC., BAUSCH & LOMB INCORPORATED, VALEANT PHARMACEUTICALS IRELAND LIMITED, ECR PHARMACEUTICAL CO., INC., TECHNOLAS PERFECT VISION GMBH, COMMONWEALTH LABORATORIES, LTD., VALEANT CANADA LP, OCEANSIDE PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., DOW PHARMACEUTICAL SCIENCES, INC., ALDEN OPTICAL LABORATORIES, INC., SANTARUS, INC, SOLTA MEDICAL, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., INKINE PHARMACEUTICAL COMPANY, INC.., BAUSCH & LOMB PHARMA HOLDINGS CORP., VALEANT PHARMA POLAND SP. Z.O.O., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, LABORATOIRE CHAUVIN S.A.S., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., SALIX PHARMACEUTICALS, INC., ONPHARMA INC., SALIX PHARMACEUTICALS, LTD., UCYCLYD PHARMA, INC., MEDICIS PHARMACEUTICAL CORPORATION | Release |
| 2025-08-13 | ASSIGNMENT OF SECURITY INTEREST IN TRADEMARKS PREVIOUSLY RECORDED AT REEL/FRAME (7717/0577) | CITIBANK, N.A., AS RESIGNING AGENT → JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | Security |
| 2025-04-08 | RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 6280/0114 | BARCLAYS BANK PLC → ATON PHARMA, INC., ORAPHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH + LOMB IRELAND LIMITED, COMMONWEALTH LABORATORIES, LLC, VALEANT PHARMACEUTICALS IRELAND LIMITED, VALEANT PHARMACEUTICALS IRELAND, INKINE PHARMACEUTICAL COMPANY, INC., TECHNOLAS PERFECT VISION GMBH, VALEANT PHARMACEUTICALS NORTH AMERICA, OCEANSIDE PHARMACEUTICALS, INC., PRIVATE FORMULA CORPORATION, BAUSCH HEALTH IRELAND LIMITED, ALDEN OPTICAL LABORATORIES, INC., SOLTA MEDICAL, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, PRECISION DERMATOLOGY, INC., EXZELL PHARMA INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, CORIA LABORATORIES, LTD., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., SANTARUS, INC., SALIX PHARMACEUTICALS, INC., BAUSCH HEALTH COMPANIES INC., VALEANT PHARMA POLAND SP. ZO.O., VALEANT INTERNATIONAL (BARBADOS) SRL, SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH US, LLC, UCYCLYD PHARMA, INC., MEDICIS PHARMACEUTICAL CORPORATION, VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L., ONPHARMA INC. | Release |
| 2025-04-08 | RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 5836/0399 | BARCLAYS BANK PLC → VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, CORIA LABORATORIES, LTD., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH IRELAND LIMITED, BAUSCH + LOMB IRELAND LIMITED, VALEO PHARMA INC., SOLTA MEDICAL, INC., BAUSCH HEALTH COMPANIES INC., COMMONWEALTH LABORATORIES, LLC, AMBI ENTERPRISES, LLC, OBAGI COSMECEUTICALS LLC, VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L., SPROUT PHARMACEUTICALS, INC. | Release |
| 2023-09-29 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. → CITIBANK, N.A., AS NOTES COLLATERAL AGENT | Transfer |
| 2022-10-21 | RELEASE OF SECURITY INTEREST IN SPECIFIED TRADEMARKS (REEL/FRAME 5836/0399) | BARCLAYS BANK PLC → BAUSCH & LOMB INCORPORATED, BAUSCH + LOMB IRELAND LIMITED | Release |
| 2022-10-21 | RELEASE OF SECURITY INTEREST IN SPECIFIED TRADEMARKS (REEL/FRAME 6280/0114) | BARCLAYS BANK PLC → BAUSCH + LOMB IRELAND LIMITED, BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 7320/0509) | THE BANK OF NEW YORK MELLON → BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6111/0139) | THE BANK OF NEW YORK MELLON → BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6280/0211) | THE BANK OF NEW YORK MELLON → BAUSCH + LOMB IRELAND LIMITED, BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 7630/0605) | THE BANK OF NEW YORK MELLON → BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6586/0877) | THE BANK OF NEW YORK MELLON → BAUSCH + LOMB IRELAND LIMITED, BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. | Release |
| 2022-05-10 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. → CITIBANK, N.A. AS COLLATERAL AGENT | Transfer |
| 2022-02-10 | SECURITY AGREEMENT | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH AMERICAS, INC. → THE BANK OF NEW YORK MELLON | Transfer |
| 2021-06-08 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH AMERICAS, INC. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2019-03-08 | CORRECTIVE ASSIGNMENT TO CORRECT THE REGISTRATION NUMBERS PREVIOUSLY RECORDED AT REEL: 006586 FRAME: 0877. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH AMERICAS, INC., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., PRIVATE FORMULA CORP., BAUSCH HEALTH US, LLC, SANTARUS, INC., SOLTA MEDICAL, INC. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2019-03-08 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., PRIVATE FORMULA CORP. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2018-02-13 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., INKINE PHARMACEUTICAL COMPANY, INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., TECHNOLAS PERFECT VISION GMBH, UCYCLYD PHARMA, INC., VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED → THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | Security |
| 2018-02-13 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., INKINE PHARMACEUTICAL COMPANY, INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., TECHNOLAS PERFECT VISION GMBH, UCYCLYD PHARMA, INC., VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED → BARCLAY'S BANK PLC, AS COLLATERAL AGENT | Security |
| 2017-07-17 | SECURITY INTEREST | BAUSCH & LOMB INCORPORATED → THE BANK OF NEW YORK MELLON | Security |
| 2016-07-18 | SECURITY INTEREST | BAUSCH & LOMB INCORPORATED, COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., OMP, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SOLTA MEDICAL, INC., SPROUT PHARMACEUTICALS, INC., TECHNOLAS PERFECT VISION GMBH, VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED, VALEANT HOLDINGS IRELAND, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS IRELAND → BARCLAYS BANK PLC | Security |
Prosecution History
60 events| Date | Event |
|---|---|
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-11 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-09-10 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-04-16 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2024-02-09 | CANCELLED SEC. 8 (6-YR) |
| 2023-10-11 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-28 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-21 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-14 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-10-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2022-10-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2022-10-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2022-10-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2022-10-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2022-07-25 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 2022-06-23 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-05-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-03-09 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2021-10-16 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-10-16 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-10-16 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-11-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2020-09-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-09-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-09-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-09-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-09-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-05-03 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-05-03 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-05-03 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2017-09-19 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2017-09-19 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2017-07-25 | REGISTERED-PRINCIPAL REGISTER |
| 2017-05-09 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2017-05-09 | PUBLISHED FOR OPPOSITION |
| 2017-04-19 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2017-03-31 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2017-03-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2017-02-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2017-02-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-02-17 | ASSIGNED TO LIE |
| 2017-02-03 | NOTICE OF REVIVAL - E-MAILED |
| 2017-02-03 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Showing first 50 of 60 events